Provided by Tiger Fintech (Singapore) Pte. Ltd.

Aptevo Therapeutics

1.49
-0.5000-25.13%
Post-market: 1.35-0.1406-9.44%19:59 EDT
Volume:4.44M
Turnover:6.79M
Market Cap:2.17M
PE:-0.02
High:1.93
Open:1.87
Low:1.23
Close:1.99
Loading ...
Aug 12, 2021

Quarterly Report

10-Q - Quarterly report [Sections 13 or 15(d)]
Aug 12, 2021

Major Issues Report

8-K - Current report
Jun 28, 2021

Major Issues Report

8-K - Current report
Jun 21, 2021

Beneficial Ownership Change

SC 13D/A [Amend] - General statement of acquisition of beneficial ownership
May 27, 2021

Major Issues Report

8-K - Current report
May 26, 2021

Major Issues Report

8-K - Current report
May 11, 2021

Quarterly Report

10-Q - Quarterly report [Sections 13 or 15(d)]
May 11, 2021

Major Issues Report

8-K - Current report
May 05, 2021

Correspondence

CORRESP [Cover] - Correspondence
Apr 28, 2021

[Rev.]Annual Report

10-K/A [Amend] - Annual report [Section 13 and 15(d), not S-K Item 405]
Mar 31, 2021

Major Issues Report

8-K - Current report
Mar 31, 2021

Annual Report

10-K - Annual report [Section 13 and 15(d), not S-K Item 405]
Feb 16, 2021

Beneficial Ownership Change

SC 13G/A [Amend] - Statement of acquisition of beneficial ownership by individuals
Feb 16, 2021

Beneficial Ownership Change

SC 13G/A [Amend] - Statement of acquisition of beneficial ownership by individuals
Feb 12, 2021

Beneficial Ownership Change

SC 13G/A [Amend] - Statement of acquisition of beneficial ownership by individuals
Feb 12, 2021

Beneficial Ownership Change

SC 13G/A [Amend] - Statement of acquisition of beneficial ownership by individuals
Feb 11, 2021

Beneficial Ownership Change

SC 13G/A [Amend] - Statement of acquisition of beneficial ownership by individuals
Feb 09, 2021

Beneficial Ownership Change

SC 13D/A [Amend] - General statement of acquisition of beneficial ownership
Dec 17, 2020

Correspondence

CORRESP [Cover] - Correspondence
Dec 14, 2020

Major Issues Report

8-K - Current report